The further experimental study of Horak et al. investigates whether it may be possible to utilize MRE11 (a constituent part of homologous recombination repair and responsible for the repair of carboplatin (CbPt)-induced DNA damage, particularly DNA crosslinks) in overcoming CbPt chemoresistance in ovarian cancer. Here, MRE11 is linked to ovarian carcinoma.